Please assess the completion status of the following clinical trial:

Trial Title: Lowering Blood Pressure in Primary Care in Vienna

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Written informed consent~* office blood pressure ≥ 140/90 mmHg~* ACE inhibitor intolerance (experimental arm)~Exclusion Criteria:~* Malignant disease with life expectancy \< 6 months~* Women of childbearing potential (ICH definition) or breastfeeding~* Contraindications or allergies against olmesartan, amlodipine or hydrochlorothiazide (experimental arm)~* Chronic kidney disease grade IV or V (eGFR \< 30 ml/min)~* Recent myocardial infarction or stroke within the preceding 3 months~* Participation in another clinical trial

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Standard Care (Type: NO_INTERVENTION): Treatment of hypertension according to current guidelines
- Experimental Care (Type: EXPERIMENTAL): Treatment of hypertension using a standardised and simplified titration regime with single pill combinations, comprising an angiotensin receptor blocker, calcium channel blocker and hydrochlorothiazide.

Based on this trial design, predict the completion outcome and termination type (if applicable).